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Introduction 
Tissue loss and organ failure are one of the 
costly health care management in all over the 
world. One of the recent strategies for the 
treatment of organ failure and damaged tissues 
is via tissue engineering technology. The 
primary goal of all approaches in tissue 
engineering is to repair and restore tissue 
functions through the delivery of living 
elements which become integrated into the 
patient (Langer and Vacanti, 1993).  
 Cartilage is an avascular tissue that has 
limited self-repair ability once damaged. A 
cartilage graft is needed for any attempt to 
restore or repair the damaged cartilage. 
Autologous cartilage is the best candidate and 
far more superior compared to allograft, 
xenograft or synthetic materials for cartilage 
repair. However, there is only limited amount 
of cartilage can be harvested without causing 
deformity and morbidity at the donor sites. 
The main objective of this study was to 
investigate the possibility of using tissue 
engineering technology to construct an 
autologous cartilage tissue for the repair of 
damaged cartilage. 
 
Materials and Methods 
 
Strategies and research approach 
The first stage of the study was to 
investigate the individual dose effects of Basic 
fibroblast growth factor (bFGF), insulin like 
growth factor-I (IGF-I) and transforming 
growth factor-beta 2 (TGF-β2) on human 
nasal septum chondrocytes. The dose effects 
were evaluated by measuring the 
chondrocytes growth rate, population 
doubling time, viability, cumulative cell 
doubling, phenotype gene expression and the 
ability of cultured chondrocytes for cartilage 
regeneration. After the optimum dose of each 
factor has been determined, the second stage 
of the study was to investigate the 
combination effects of growth factors on 
human nasal septum chondrocytes. The effects 
of insulin-transferrin-selenium and serum 
concentration were also evaluated in this 
stage. The third stage of the study was to 
investigate a neocartilage formation technique 
without using any scaffold material. 
 
Human nasal septum chondrocyte isolation 
and culture expansion 
      Human nasal septum cartilages were 
obtained from consented adult patients after 
elective septoplasty. These specimens would 
usually be discarded and their used in this 
study has been approved by the Ethical 
Committee of Medical Faculty, Universiti 
Kebangsaan Malaysia. Each cartilage was 
cleaned from perichondrium, minced into 
small pieces (1mm3) and digest with 0.6% 
collagenase II (Gibco) at 370C for 12 hours. 
After digestion, total cell quantification was 
done with hemocytometer. Viability of 
chondrocytes was determined with trypan blue 
vital dye exclusion test (Gibco). 
      Isolated chondrocytes were seeded in 
tissue culture plate (Falcon) at a cell density of 
5,000 cells/cm2 in an equal volume mix of 
Ham’s F12 medium and Dulbecco’s Modified 
Eagle Medium (Gibco) added with 1%(v/v) 
200mM L-glutamine (Gibco), 1%(v/v) 
antibiotic-antimycotic (Gibco) and 1%(v/v) 
ascorbic acid (Sigma). This culture medium 
was then added with different test components 
such as fetal bovine serum (FBS; Gibco), 
pooled human serum (HS), insulin-transferrin-
selenium (ITS), basic fibroblast growth factor 
(bFGF), transforming growth factor-beta2 
(TGF-β2) and insulin-like growth factor-I 
(IGF-I) for individual dose effects 
investigation and combination study.  All 
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cultures were maintained in 5% CO2 incubator 
at 370C with culture media changed twice a 
week. Cultures were examined everyday 
under inverted light microscope to monitor the 
growth of culture.  
     When the primary culture (P0) reached 
confluence, it was trypsinized with pre-
warmed (370C) 0.05% trypsin-0.53mM EDTA 
(Gibco). Cultured chondrocytes were then 
passaged three times (P1, P2 and P3) with the 
same cell seeding density, culture medium and 
culture environment. Total cell count and cell 
viability were recorded at every passage. 
Chondrocyte growth rate, population doubling 
time and cumulative cell doubling in each 
media at every passage (P0, P1, P2 and P3) 
was then calculated for statistical analysis 
(ANOVA and Student’s t test). 
 
Chondrocyte phenotype gene expression 
evaluation 
Total RNA from cultured chondrocytes in 
different experiment groups were extracted 
using TRI Reagent (Molecular Research 
Center, Cincinnati, OH) according to the 
manufacturer’s instruction. Polyacryl Carrier 
(Molecular Research Center) was added in 
each extraction to precipitate the total RNA. 
Extracted RNA pellet was then washed with 
75% ethanol and dried before dissolved in 
Rnase and Dnase free distilled water 
(Invitrogen, Carlsbad, CA). Yield and purity 
of the extracted RNA was determined by 
spectrophotometer (Bio-Rad, Hercules, CA). 
Total RNA was stored at -800C immediately 
after extraction.  
Expression of type I and type II collagen 
genes was evaluated by one step reverse 
transcriptase-polymerase chain reaction (One 
Step RT-PCR; Invitrogen). Expression of 
human β-actin gene was used as control. The 
specific sense and antisense primers used in 
the reaction were designed from listed NIH 
GenBank database and has the following 
sequences: type I collagen, 5′-
AAGGCTTCCAAGGTCCCCCTGGTG-3′ 
and 5′-
CAGCACCAGTAGCACCATCATTTC-3′; 
type II collagen, 5′-
CTGGCAAAGATGGTGAGACAGGTG-3′ 
and 5′-GACCATCAGTGCCAGGAGTGC-3′; 
β-actin, 5′-CCGGCTTCGCGGGCGACG-3′ 
and 5′-TCCCGGCCAGCCAGGTCC-3′. One 
Step RT-PCR reaction mix was prepared 
according to the manufacturer’s instruction. 
Each reaction consisted of 100ng total RNA 
and 10pmol of each sense and antisense 
primers. One step RT-PCR was performed in 
a 9700 thermal cycler (Perkin Elmer, 
Norwalk, CT) with reaction profile of; cDNA 
synthesis for 30 min at 500C; pre-denaturation 
for 2 min at 940C; PCR amplification for 38 
cycles with 30 sec at 940C, 30 sec at 600C and 
30 sec at 720C. This series of cycles was 
followed by a final extension of 720C for 2 
min. Subsequently, the PCR products were 
separated by electrophoresis on a 1.5% 
agarose gel stained with ethidium bromide and 
visualized by UV transillumination.  
 
In vivo cartilage regeneration and evaluation 
Cultured chondrocytes from different 
growth factors experiments were suspended 
into a 30% (wt/vol) of a co-polymer of 
polyethylene oxide and polypropylene oxide, 
Pluronic F-127 (BASF, Mount Olive, NJ) at 
40C with a cell density of 3 x 107 cells/ml. The 
resulted admixer was then injected 
subcutaneously at the dorsal part of the nude 
mice under general anesthesia (ketamine, 
xylazil and zoletil). Care of the nude mice was 
carried out following the animal facility 
guideline of the Animal Unit, Institute 
Medical Research Malaysia.  
The regenerated/engineered tissues were 
harvested after 8 weeks of in vivo 
implantation. The nude mice were sacrificed 
by anesthetic overdose and engineered tissues 
were carefully dissected free from 
surrounding soft tissue. The engineered tissue 
was divided into three parts with one part 
fixed in 10% phosphate buffered formalin and 
processed into paraffin embedded block. 
Paraffin blocks were then sectioned and the 
slides sections were stained with standard 
histological staining; Hematoxylin & Eosin 
(H&E staining) and Safranin O staining. 
Another part of the excised tissue was 
digested with Collagenase II enzyme and total 
RNA was extracted for one-step RT-PCR 
analysis as mentioned earlier. 
      Part of the engineered tissues was also 
evaluated with electron microscopy technique 
in Universiti Putra Malaysia. The tissues were 
cut into 1mm3 blocks, fixed in 2.5% 
glutaraldehyde (Sigma) for 24 hours. Tissues 
blocks were then post-fixed in 1% osmium 
tetraoxide for 2 hours, dehydrated, infiltration 
with resin, embedding, ultra-thin sectioned, 
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stained with 2% uranyl acetate and examined 
with CX-2000 transmission electron 
microscope (JEOL, Tokyo, Japan). 
 
Technique of tissue engineered human 
cartilage formation without scaffold material 
Chondrocytes were seeded onto 175cm2 
flask and culture in medium consists of 10% 
serum. Cultures were allowed to be over grew, 
formed multilayer and then chondrocyte mass 
within 3 weeks. The chondrocyte mass was 
further maintained until the constructs 
established stable size and shape. These 
constructs were then implanted 
subcutaneously on the dorsal part of nude 
mice for 8 weeks. After 8 weeks of 
implantation, the in vivo engineered constructs 
were removed and evaluated by histological 
staining, one step RT-PCR and transmission 
electron microscopy for its quality. 
 
Results 
 
Human nasal septum chondrocytes 
Morphologic Feature in Monolayer Culture 
Human nasal septum chondrocytes 
cultured in different growth factors 
supplementation exhibited different 
morphologic features in monolayer culture. 
Chondrocytes were different in size, shape 
and density under influence of various growth 
factors.  
 
Human nasal septum chondrocytes growth 
kinetic and phenotype gene expression 
The optimum dosage of Basic fibroblast 
growth factor (bFGF), insulin like growth 
factor-I (IGF-I) and transforming growth 
factor-beta 2 (TGF-β2) were obtained in dose 
response graph (data not shown). 
Chondrocytes growth rate in culture medium 
supplemented with different combination of 
optimum growth factors dosage was 
demonstrated in Figure 1. The combination of 
10µg/ml insulin + 5.5µg/ml transferrin + 
6.7ng/ml sodium selenite (ITS) + 5ng/ml IGF-
I + 3ng/ml bFGF and 1ng/ml TGF-β2 
provided the highest chondrocyte growth rate 
(Figure 1). This combination of various 
growth factors was also capable to retain the 
cartilage phenotype of cultured chondrocytes 
by maintaining type II collagen gene 
expression until passage 3 (Figure 2).  
 
Engineered/regenerated tissues evaluation 
After 8 weeks of in vivo implantation, the 
Safranin O staining on the engineered tissue 
sections showed strong orange-red staining 
demonstrating abundant proteoglycans 
production (Figure 3A). Hematoxylin & Eosin 
staining demonstrated engineered tissues 
consisted of evenly spaced lacunae cells 
embedded in basophilic matrix (Figure 3B). 
Transmission electron micrographs showed 
cells in the engineered tissues were cuboidal 
in shape with cytoplasm processes extended 
into the extracellular matrix (Figure 3C). The 
cells were rich with mitochondria and 
endoplasm reticulum for protein production. 
The presence of abundant collagen fibrils was 
noted as the major component in the 
extracellular matrix (Figure 3C). One step RT-
PCR analysis on the total RNA extracted from 
engineered tissues display high level 
expression of type II collagen gene (Figure 
3D).   
 
Formation of tissue engineered human 
cartilage without scaffold material 
In this technique, multilayer chondrocyte 
culture was detached away from the edge of 
the flask and aggregated to form chondrocyte 
mass which appear like jellyfish (Figure 4A). 
At the end of third week of in vitro culture, 
the chondrocyte mass reached its steady stage 
(refer as neocartilage) and was mechanically 
strong enough for implantation (Figure 4B). 
At this stage, Safranin O staining on the 
neocartilage section demonstrated no orange-
red staining which indicate negative 
production of cartilage proteoglycans (Figure 
4C). After 8 weeks of in vivo implantation, 
this neocartilage was able to develop into a 
mature cartilage demonstrated by positive 
staining of Safranin O (Figure 4D). The 
removed tissues were glistening white in color 
and firm in consistency, resemble the native 
cartilage (Figure 4E). 
 
Discussion 
Human nasal septum chondrocyte growth 
kinetic data showed basic fibroblast growth 
factor (bFGF) is a powerful mitogen 
(Ruszymah et al., 2002) among other tested 
growth factors. The mitogenic effects of bFGF 
come into saturation at 3-5ng/ml 
concentration in the culture medium (Chua et 
al., 2002b). Further increase in bFGF  
A
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FIGURE 1 Human chondrocyte growth rate (Increase in number of cells/days/cm2) in medium 
Supplemented with various growth factors at primary culture. Values were showed as mean ± SEM (n 
= 6). ∗ Medium supplemented with ITS + 5ng/ml IGF-I + 3ng/ml bFGF + 1ng/ml TGF-β2 showed 
significant higher growth rate than other groups. p<0.05. ITS = Insulin-transferrin-selenium. IGF-I = 
5ng/ml insulin like growth factor-I. bFGF = 3ng/ml fibroblast growth factor. TGF-beta2 = 1ng/ml 
transforming growth factor-beta 2. 
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FIGURE 2 One step RT - PCR analysis on the gene expression of chondrocytes from native cartilage  
( NC ), primary culture ( P0 ), passage 3 in various growth factors supplemented m edium ( P3GF ) and  
passage 3 in medium without growth factor ( P3 ). Chondrocytes cultured in medium supplemented with  
growth factors retained type II collagen gene expression. Lane M: 100bp DNA marker. Lane C: β -actin  
gene fragment (Control; 495bp). Lane I: T ype I collagen gene fragment (396bp). Lane II: Type II  
collagen gene fragment (294bp).  
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FIGURE 3 Evaluation on engineered/regenerated tissue. Safranin O staining showed positive orange -red 
staining indicate abundant proteoglycans production, x 40 ( A). Hematoxylin & Eosin staining demonstrated 
lacunae cells embedded in  basophilic matrix, x 400 ( B). Transmission electron micrographs showed cell in 
engineered tissue was cuboidal in shape, rich with mitochondria and endoplasm reticulum. Abundant  
collagen fibril was noted in the extracellular matrix, x 4000 ( C). One step RT -PCR analysis showed high 
expression of type II collagen gene in the engineered tissue ( D).  
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concentration will only cause unnecessary 
addition of cost and may result in longer 
period of time for cartilage regeneration. In 
growth factor combination study, bFGF reacts 
synergistically with transforming growth 
factor-β2 to promote human nasal septum 
chondrocyte proliferation. The optimum 
combination of bFGF at 3.0ng/ml with TGF-
β2 at 1.0ng/ml concentration was able to 
promote good quality engineered cartilage 
tissue formation (Chua et al., 2003a). 
Addition of Insulin-transferrin-selenium (ITS) 
into the culture medium promoted higher 
chondrocyte proliferation and cartilage 
regeneration (Chua et al., 2003b). Insulin like 
growth factor-I was later proven to be 
beneficial of retaining the cartilage phenotype 
expression in the culture medium (Chua et al., 
2004b). In order to overcome problems on 
using animal sera, such as viral-cause disease 
transmission, the danger of prion 
contamination and immune reaction against 
animal serum proteins, the effects of human 
serum were also investigated in the study and 
was shown that it provided additional values 
of supporting the growth and differentiation of 
human nasal septum chondrocytes (Ruszymah 
et al., 2003; Chua et al., 2004a). 
This study managed to formulate a human 
chondrocytes growth medium resulted from 
the combination of various growth factors in a 
specific concentration. The medium 
formulation was found novel and managed to 
fail for a patent (PI20041917) in the name of 
UKM-MECC. UKM-MECC is capable to 
support 178,000 fold increases in chondrocyte 
number and maintained the cartilage 
phenotype during expansion. Culture-
expanded chondrocytes were able to form 
high quality cartilage tissue in nude mice 
model after 8 weeks of implantation. UKM-
MECC was also showed to be cost effective 
and valuable for clinical application of 
cartilage tissue engineering.  
The novel technique on constructing tissue 
engineered human cartilage without scaffold 
material is able to generate high quality 
cartilage after implantation.  This new 
technique is potential for the repair of various 
cartilage defects since it has eliminated the 
problem of immune-reaction (Chua et al., 
2002a; Ruszymah et al., 2002; Aminuddin et 
al., 2003).  
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FIGURE 4 Early formation of chondrocyte mass in the form of jellyfish like (A). Chondrocyte mass
reached its steady stage (neocartilage) (B). Safranin O staining showed negative staining on the
neocartilage, x 40 (C). Safranin O staining showed positive staining on engineered tissue after 8 weeks of
in vivo implantation, x 40 (D). The removed tissues were glistening white in color and firm in consistency
at physical appearance (E).  
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